Skip to content

Harnessing deep learning
to prevent blindness



Artificial intelligence could help prevent eye damage and sight loss in people with diabetes and save NHS millions of pounds annually MONDAY 6THJULY 2020 Results from the largest study of artificial intelligence use in the...

Read More »


技术教程-优创资源网 - iuczy:2021-1-14 · 付费 SVIP免费 SVIP优惠 发布日期 修改时间 评论数量 随机 热度 技术教程 修复链接全系统翻墙Shadowrocket小火箭免费安装及完整图文使用下载教程 [ 带节点 – 一键订阅 ] 2021-01-14 技术教程 ...

Read More »


May 26, 2020 WebMD digital publication “Artificial intelligence and You” highlights Eyenuk innovations under the section “AI Already Transforms Medicine”. “A screening system devel­oped by a California-based company called Eyenuk Inc. can detect diabetic retinopathy,...

Read More »


shadowrocket节点购买 - 好看123:2021-9-30 · 2.苹果小火箭shadowrocket节点几种添加方式,怎么用法?咔咔团 点击前往 网站介绍:苹果小火箭现在只能在美区下载到,下载的时候需要2.99美金,可以礼品卡购买,也可以登陆别人的美区账号,直接在美区的appstore里搜索shadowrocket,如果别人已经付费过,...



The Ophthalmology Innovation Summit (OIS) website has published an article titled, “Eyenuk’s EyeArt AI System Showing Its Value” highlighting Eyenuk’s recent success. Link to the full article on website: Eyenuk’s EyeArt AI System Showing...

Read More »

Introducing EyeArt®

The EyeArt® AI Eye Screening System is the most extensively validated AI technology for autonomous detection of diabetic retinopathy, tested on over half a million patient visits globally with over two million images collected in real-world clinical environments.

 Watch Video
   Product Tour      
Real World Use

* EyeArt® has been cleared for sales as a Class IIa medical device by EU and as a Class 2 medical device by Health Canada.
** In the United States, EyeArt® is limited by federal law to investigational use only and is not available for sale.



The EyeArt system provides automated diabetic retinopathy screening without the need for expert human grading or eye dilation, enabling 付费shadowsock账号哪里买 - 马洪飞博客:2021-12-11 · 付费shadowsock账号哪里买? 这个问题很难回答,目前科学上网一半可以分为以下几种: ss ssr v2ray wireguard 1和2目前阻断比较严重,墙高了。。。 3的话目前直接tcp阻断严重,ws的话偶尔有阻断,ws + tls 目前还可以,暂时无阻断,待观察。.


The EyeArt system autonomously analyzes patient's retinal images acquired using an integrated fundus camera, robustly detects signs of disease, and returns an easy-to-read report in under 60 seconds.


The EyeArt system incorporates a number of deep learning and image analysis algorithms to automatically assess the quality of the images, detect the presence and extent of lesions, and shadowrocket节点购买 - 好看123:2021-9-30 · 2.苹果小火箭shadowrocket节点几种添加方式,怎么用法?咔咔团 点击前往 网站介绍:苹果小火箭现在只能在美区下载到,下载的时候需要2.99美金,可以礼品卡购买,也可以登陆别人的美区账号,直接在美区的appstore里搜索shadowrocket,如果别人已经付费过,....


Why choose EyeArt?

The EyeArt system is the world’s most-validated artificial intelligence (AI) screening tool for diabetic retinopathy, demonstrating high real-world sensitivity and specificity. It is proven to be safe, fast, and consistent.

* Claims on this page have not been evaluated by US FDA

Exceptional Performance in Pivotal, Prospective, Multi-Center Clinical Trial

EyeArt System Achieved MieLink羊圈账户注册、套餐购买和Trojan客户端配置使用 ...:2021-4-13 · 回国套餐 月付 季付 年付 流量 100G 100G 100G 价格 39元 117元 412元 叠加流量包 7.5元/50G,必须跟已买套餐叠加使用,单买无效。套餐权益 数条中国大陆节点,支持2个公网IP同时在线;免费远程技术支持,12*365在线客服支持,已解锁国内音乐 ..., While Meeting All Primary Endpoints with p<0.0001

Dr. Jennifer I. Lim, MD, Marion H. Schenk Esq. Chair, Professor of Ophthalmology, and Director of Retina Service at the University of Illinois at Chicago presented the Eyenuk Clinical Trial study results at the ARVO 2019 Imaging in the Eye Conference in Vancouver, Canada. Dr. Lim spoke to MD Magazine about the study in a multi part interview series. Click on the video to watch the interview.


In a study with over 100,000 consecutive patient visits, EyeArt reports a 91.3% sensitivity and 91.1% specificity for referable DR and a 98.5% sensitivity for vision-threatening DR.

Experience EyeArt

* These claims have not been evaluated by US FDA


Elevate Patient Care with the Confidence of AI Eye Screening

The high-performance EyeArt AI algorithm automatically detects diabetic retinopathy quickly, accurately, and consistently, with higher sensitivity than an eye care expert trained in image grading.

The EyeArt system is easy to use and with minimal training can be employed by nurses or technicians, enabling diabetic retinopathy screening at the point of care and eliminating an eye care specialist appointment just for screening.

Know More ▶


Undiagnosed Diabetic Retinopathy is a Thing of the Past

AI Eye Screening with EyeArt helps remove the biggest obstacle to annual DR screening and diagnosis: patient compliance.

The EyeArt system makes it possible for any physician to identify patients with vision-threatening retinopathy in-clinic, in real-time, so they can be immediately referred to an eyecare specialist for treatment to save their sight.


Test and Give Results to Patients in the Same Appointment

Whether you work with diabetes patients as a general practitioner, endocrinologist, diabetologist, ophthalmologist, or an optometrist, EyeArt can enable fast, reliable, and accurate diabetic retinopathy screening for your patients.

Find out how easy it is to incorporate the EyeArt system into your practice.

Know More ▶

Want to try EyeArt?

EyeArt can be seamlessly integrated with your clinical workflow to enable automated DR screening.
Click to get started.

Experience EyeArt

* EyeArt® has been cleared for sales as a Class IIa medical device by EU and as a Class 2 medical device by Health Canada.
** In the United States, EyeArt® is limited by federal law to investigational use only and is not available for sale.


Products under development. Click here to know more.


Accurately Track
Retinopathy Progression

EyeSee AMD


EyeSee Glaucoma

Fully-Automated Glaucoma screening


Mobile DR Screening
on your Phone

* EyeMark™, EyeApp™, EyeSeeAMD™, EyeSeeGlaucoma™ have not yet been cleared for sales in any region.


EyeArt could have a huge impact in improving the lives of individuals with diabetes who still face the risk of losing vision asymptomatically

Prof. Andrew Boulton, MD, DSc(Hon), FACP, FRCP

Renowned Diabetes Expert, Professor of Medicine, University of Manchester, UK

I believe that an automated, reliable DR screening tool such as EyeArt would empower primary care providers to better manage their patients with diabetes.


President and CSO, Doheny Eye Institute, Los Angeles, USA

I believe that automation of common tasks like DR screening would have a tremendous impact on the quality and extent of vision care for the disparity populations. Therefore I am eager to work with EyeArt tool for DR screening.


Distinguished Professor and Chairman, Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA (Former President of ARVO)

...results of the large scale validation on over 100,000 patient encounters from the EyePACS database are highly encouraging and show that EyeArt can be a safe and effective alternative to manual screening.

Dr. Jorge Cuadros, OD, PhD

CEO of EyePACS, Assistant Clinical Professor, UC Berkeley School of Optometry, CA, USA

EyeArt’s automatic lesion detection and DR screening will allow us to better monitor our teleretinal patients at a lower cost in the under-resourced setting in which we care for Los Angeles’s most disadvantaged patients.

Dr. Lauren P. Daskivich, MD, MSHS

Director of Ophth. and Eye Health Programs, LA County Department of Health Services, Los Angeles, CA, USA

Eyenuk in the news


Select Collaborators, Customers, & Partners


The Doheny Eye Institute in Los Angeles, CA is recognized as a leading center for eye disease and vision research.


The Los Angeles County Department of Health Services safety net serves more than 800K patients annually and runs a teleretinal DR screening program.


Madras Diabetes Research Foundation (MDRF) in India was established in 1996. It's a premier research institute for diabetes and its complications.



Washington University School of Medicine, St. Louis, MO is one of the leading medical research, teaching and patient care institutions in the US.


The Armenian Eyecare Project (AECP) is a nonprofit organization dedicated to providing the Armenian people eye care to help eliminate preventable blindness.


Diabetes Clinic Bad Mergentheim (Germany) is a specialist hospital for inpatient diabetes treatment.


The National Health Service (NHS) is the public health service system of the United Kingdom. NHS runs the largest DR screening program in the world.


innofo: 谷歌云回程是走专线的,去程163,不过只要丢包不 ...:20 小时前 · 谷歌云回程是走专线的,去程163,不过只要丢包不严重,影响不大 - innofo 说在 社群 Shadowrocket 在 2021年6月18日星期四凌晨4点25分


Eye Picture Archive Communication System is a non-proprietary web-based application for exchanging eye-related clinical information.

ysscloud加速器官网  加速猫app  旋风加速器的官网在哪里   netpas云墙安卓版进加速器   用手机上油管加速软件  ssr机场推荐2022